Physician profile
Collin Ray
NPI 1194567511
$708.60
in general payments reported to CMS, 2019-2025
9 companies · $377 in 2025
The $377 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $331 · 2025: $377.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $709.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $708.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Fusion Orthopedics USA, LLC | $152.54 | 2024-2025 | |
| Nevro Corp. | $126.33 | 2024 | Senza |
| Solventum Corporation | $108.64 | 2025 | Prevena, Activ.A.C., V.A.C. Veraflo Cleanse Choice |
| Organogenesis INC. | $64.90 | 2025 | Puraply Wound Matrix |
| Zimmer Biomet Holdings, INC. | $64.47 | 2024 | |
| Stryker Corporation | $60.27 | 2025 | Prostep Mica |
| Mf Med | $49.74 | 2024-2025 | |
| Paragon 28, INC. | $45.10 | 2024-2025 | Phantom Fibula Nail, Monkey Bars |
| Kerecis Limited | $36.61 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Collin Ray listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.